Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 6,709-6,720 of 10,592
Drug study icon
CompletedNCT00857220

Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia

This study exists to better understand the safety of the medication Study and how manageable it feels in practice. Researchers are trying to understand whether the medication Study can improve attention, thinking, or day-to-day functioning.

In United States
ADHDDrugA study involving a medication or substance.From 6 Years to 17 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
ADHD
Behavioral study icon
CompletedNCT02867124

Long-acting Naltrexone for Pre-release Prisoners

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionBehavioralOver 18 Years
Countries
United States
Sponsor
Friends Research Institute, Inc.
Condition
Addiction
Drug study icon
CompletedNCT00257725

Long-Duration Stimulant Treatment Study of ADHD in Young Children

This study exists to explore whether the medication ADHD could improve care and understanding. Researchers are trying to understand whether the medication ADHD can improve attention, thinking, or day-to-day functioning.

In United States
ADHDDrugFrom 4 Years to 5 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
ADHD
Behavioral study icon
WithdrawnNCT06733558

Long-term Potentiation Disruption Underlying Cognitive Impairment in ECT

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In United States
Depression, BipolarityBehavioralFrom 18 Years to 80 Years
Countries
United States
Sponsor
University of New Mexico
Condition
Depression, Bipolarity
Drug study icon
CompletedNCT01059539

Long-term Safety and Tolerability of Cariprazine for Bipolarity type I

This study exists to understand how this type of care holds up over time after the earliest research stage. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Hungary, Poland, ...
Sponsor
Forest Laboratories
Condition
Bipolarity
Drug study icon
Enrolling By InvitationNCT04987229

Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

This study is looking at care and outcomes for people with Bipolarity I or Schizophrenia. Taking part may give some people access to OLZ/SAM, but direct benefit is not guaranteed.

In United States
Schizophrenia, BipolarityDrugFrom 10 Years to 17 Years
Countries
United States, Argentina, Brazil, ...
Sponsor
Alkermes, Inc.
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT01395992

Long-Term Safety Extension study of Asenapine in Bipolarity type I Participants Who Completed Protocol P05691 (P05692)

This study exists to understand how the medication Asenapine holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication Asenapine in practice and what may need to be adjusted.

In United States
BipolarityDrugOver 18 Years
Countries
United States
Sponsor
Forest Laboratories
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.